On October 8, PHARMARON fell 3.11% in regular trading, trading at 31.18 HKD/share, with Turnover of 1.71 billion HKD.

On the news front, JPMorgan Chase & Co.'s frequent stake changes in the company have drawn market attention. On October 2, the institution acquired 5.04 million H-shares off-exchange at an average price of 30.3211 HKD per share, raising its long position ratio to 15.30%. However, the institution had reduced its holdings on September 30 and October 1, causing the ratio to drop from 15.31% to 13.90%. Although the latest disclosure shows a re-increase, the short-term volatility in the long position ratio has pressured market sentiment.

Meanwhile, the broader CRO sector weakened on the same day, with WuXi Biologics, WuXi AppTec, and GenScript Biotech all declining to varying degrees, reflecting a cautious industry mood.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)